Stocks
baxalta IncorporatedBXLT
YHDHealthcareBiotechnology
A biopharmaceutical developer focused on therapies for hemophilia, immune disorders, and other rare diseases, created through the 2015 spin-off of Baxter International’s biopharma unit. The company marketed plasma-derived and recombinant treatments while advancing a pipeline targeting hematology and...
Congressional Interest in baxalta Incorporated (BXLT)
5 members of Congress have disclosed 9 trades in baxalta Incorporated (BXLT), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
5
Buys
0
Sells
7
Who in Congress Is Trading BXLT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-06-03 | Richard L. Hanna | sell | $100K – $250K |
| 2015-10-26 | K. Michael Conaway | sell | $1K – $15K |